Ceria nanoparticles for use in the treatment of hepatocellular carcinoma

Section menu

This invention relates the use of cerium oxide single crystal nanoparticles (CeO₂NPs) in the treatment of Hepatocellular Carcinoma (HCC). This treatment increases the survival of treated animals and reduce the proliferation of cancer cells.

See the full patent.

Download brochure

Updated: 16 October 2017

Licensed Technology: No

Involved research Group: Inorganic Nanoparticles

ICN2 researchers involved: Víctor F. Puntes